| Literature DB >> 26608545 |
Bunyapon Sukpraphrute1, Brandon C Drafts2, Pairoj Rerkpattanapipat3, Timothy M Morgan4, Paul M Kirkman5, William O Ntim6, Craig A Hamilton7, Robert L Cockrum8, W Gregory Hundley9,10.
Abstract
BACKGROUND: Left ventricular wall motion abnormalities (LVWMA) observed during cardiovascular magnetic resonance (CMR) pharmacologic stress testing can be used to determine cardiac prognosis, but currently, information regarding the prognostic utility of upright maximal treadmill induced LVWMA is unknown. Our objective was to determine the prognostic utility of upright maximal treadmill exercise stress CMR.Entities:
Mesh:
Year: 2015 PMID: 26608545 PMCID: PMC4660781 DOI: 10.1186/s12968-015-0208-z
Source DB: PubMed Journal: J Cardiovasc Magn Reson ISSN: 1097-6647 Impact factor: 5.364
Fig. 1Upright Treadmill Exercise CMR Stress Test Protocol. CMR scanner with shoulder harnesses (black arrows) to aid with correct patient positioning (a), obtaining rest cine imaging (b), placement of electrode patches and blood pressure cuff for patient monitoring (c), treadmill exercise stressing (d), and repositioning the patient into the scanner for post-stress cine images (e)
Fig. 2Rest and Stress CMR Images of the Left Ventricle in the Short-Axis View. Cine CMR images of the left ventricle in the mid-short axis view at end-diastole and end-systole during rest (top row) and after maximal upright treadmill exercise stress (bottom row) in participants without (left) and with (right) treadmill exercise-induced left ventricular wall motion abnormality (LVWMA). White arrows mark an area of inadequate thickening of the left ventricular myocardium indicative of an inducible LVWMA associated with myocardial ischemia
Demographic data and summary of events
| ALL | Reached 80 % target HR or ischemia | Inducible LVWMA | No Inducible LVWMA |
| |
|---|---|---|---|---|---|
| Patient characteristics | |||||
| Patients |
|
|
|
| |
| Age, yrs | 59 ± 13 | 59 ± 13 | 62 ± 12 | 58 ± 14 | 0.17 |
| Gender men | 71 (62) | 59 (59) | 21 (70) | 38 (54) | 0.18 |
| BMI, kg/m2 | 28.4 ± 5.9 | 28.1 ± 5.9 | 29.4 ± 6.4 | 27.5 ± 5.5 | 0.13 |
| LVEF, % | 58 ± 10 | 58 ± 10 | 56 ± 11 | 59 ± 9 | 0.091 |
| Historical Information | |||||
| Prior MI | 29 (25) | 24 (24) | 11 (37) | 13 (19) | 0.073 |
| Hypertension | 63 (55) | 51 (51) | 22 (73) | 29 (41) | 0.004 |
| Hyperlipidemia | 74 (64) | 61 (61) | 25 (83) | 36 (51) | 0.003 |
| Diabetes | 24 (21) | 20 (20) | 9 (30) | 11 (16) | 0.11 |
| Smoking | 35 (30) | 35 (35) | 8 (27) | 19 (27) | 1.00 |
| Events | |||||
| All Cardiac Events | 30 (26) | 24 (24) | 14 (47) | 10 (14) | 0.002 |
| Cardiac Death / MI | 8 (7) | 7 (7) | 5 (17) | 2 (3) | 0.024 |
Values are expressed as n (%), unless otherwise indicated
BMI body mass index, LVEF left ventricular ejection fraction, LVWMA left ventricular wall motion abnormalities, MI myocardial infarction
Hemodynamic data
| All | Reached 80 % target HR or ischemia | Inducible LVWMA | No Inducible LVWMA |
| |
|---|---|---|---|---|---|
| Resting HR (beats/min) | 78 ± 14 | 78 ± 13 | 76 ± 14 | 80 ± 13 | 0.36 |
| Peak HR (beats/min) | 136 ± 21 | 161 ± 13 | 158 ± 12 | 162 ± 14 | 0.17 |
| % MPHRR | 88 ± 12 | 91 ± 11 | 87 ± 14 | 93 ± 6 | 0.009 |
| METS | 9 ± 3 | 9.5 ± 3.4 | 8.0 ± 3.1 | 10 ± 3 | 0.004 |
| Resting SBP (mm Hg) | 138 ± 23 | 139 ± 23 | 144 ± 20 | 137 ± 24 | 0.23 |
| Peak SBP (mm Hg) | 158 ± 23 | 158 ± 23 | 164 ± 25 | 155 ± 22 | 0.20 |
| Resting DBP (mm Hg) | 74 ± 12 | 75 ± 12 | 75 ± 8 | 75 ± 13 | 0.89 |
| Peak DBP (mm Hg) | 81 ± 9 | 81 ± 9 | 76 ± 9 | 83 ± 9 | 0.18 |
DBP diastolic blood pressure, HR heart rate, MPHRR maximum predicted heart rate response, SBP systolic blood pressure; other abbreviations as in Table 1
Cardiac events (expressed as total number of those achieving 80 % MPHRR for age and percent)
|
| |
|---|---|
| Unstable angina warranting hospitalization | 11 (11) |
| Coronary artery revascularization | |
| PCI | 6 (6) |
| CABG | 0 (0) |
| Myocardial infarction | 6 (6) |
| Cardiac death | 1 (1) |
PCI percutaneous coronary interventions
CABG coronary artery bypass graft
MPHRR maximum predicted heart rate response
Fig. 3Kaplan-Meier Survival Plots. Survival plots showing the proportion of participants free from cardiac events (any cardiac events, top; hard cardiac events, bottom) versus time. Participants without inducible ischemia are indicated by red dashed lines and those with inducible ischemia are indicated by the black solid lines